Video encyclopedia


Basmisanil (INN) is a highly selective inverse agonist/negative allosteric modulator of α5 subunit-containing GABAA receptors which is under development by Roche for the treatment of cognitive impairment associated with Down syndrome. As of June 2016, it is no longer studied.
Explore contextually related video stories in a new eye-catching way. Try Combster now!